|
Volume 272, Number 17,
Issue of April 25, 1997
pp. 11557-11565
©1997 by The American Society for Biochemistry and Molecular Biology, Inc.
Reversion of Ras- and Phosphatidylcholine-hydrolyzing
Phospholipase C-mediated Transformation of NIH 3T3 Cells by a Dominant
Interfering Mutant of Protein Kinase C Is Accompanied by the Loss
of Constitutive Nuclear Mitogen-activated Protein Kinase/Extracellular
Signal-regulated Kinase Activity
(Received for publication, July 8, 1996, and in revised form, February 3, 1997)
Geir
Bjørkøy
,
Maria
Perander
,
Aud
Øvervatn
and
Terje
Johansen
From the Department of Biochemistry, Institute of Medical Biology,
University of Tromsø, 9037 Tromsø, Norway
The transformed phenotype of v-Ras- or
Bacillus cereus phosphatidylcholine-hydrolyzing
phospholipase C (PC-PLC)-expressing NIH 3T3 cells is reverted by
expressing a kinase-defective mutant of protein kinase C ( PKC).
We report here that extracellular signal-regulated kinase (ERK)-1 and
-2 are constitutively activated in v-Ras- and PC-PLC-transformed cells
in the absence of added growth factors. Interestingly, the activated
ERKs were exclusively localized to the cell nucleus. Consistently, the
transactivating potential of the C-terminal domain of Elk-1, which is
activated upon ERK-mediated phosphorylation, was strongly induced in
serum-starved cells expressing v-Ras or PC-PLC. Reversion of v-Ras- or
PC-PLC-induced transformation by expression of dominant negative PKC
abolished the nuclear ERK activation suggesting PKC as a novel,
direct or indirect, activator of mitogen-activated protein kinase/ERK kinase in response to activated Ras or elevated levels of
phosphatidylcholine-derived diacylglycerol. Transient transfection
experiments confirmed that PKC acts downstream of Ras but upstream
of mitogen-activated protein kinase/ERK kinase. We found both the
v-Ras- and PC-PLC-transformed cells to be insensitive to stimulation
with platelet-derived growth factor (PDGF). No detectable receptor
level, autophosphorylation, or superinduction of DNA synthesis could be
observed in response to treatment with PDGF. Reversion of the
transformed cell lines by expression of dominant negative PKC
restored the receptor level and the ability to respond to PDGF in terms
of receptor autophosphorylation, ERK activation, and induction of DNA
synthesis.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
M. E. Nolan, V. Aranda, S. Lee, B. Lakshmi, S. Basu, D. C. Allred, and S. K. Muthuswamy
The Polarity Protein Par6 Induces Cell Proliferation and Is Overexpressed in Breast Cancer
Cancer Res.,
October 15, 2008;
68(20):
8201 - 8209.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. P. Regala, C. Weems, L. Jamieson, J. A. Copland, E. A. Thompson, and A. P. Fields
Atypical Protein Kinase C{iota} Plays a Critical Role in Human Lung Cancer Cell Growth and Tumorigenicity
J. Biol. Chem.,
September 2, 2005;
280(35):
31109 - 31115.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Lee, J.-Y. Kim, and W. B. Anderson
Src Tyrosine Kinase Inhibitor PP2 Markedly Enhances Ras-independent Activation of Raf-1 Protein Kinase by Phorbol Myristate Acetate and H2O2
J. Biol. Chem.,
November 19, 2004;
279(47):
48692 - 48701.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. D. Savkovic, A. Koutsouris, and G. Hecht
PKC{zeta} participates in activation of inflammatory response induced by enteropathogenic E. coli
Am J Physiol Cell Physiol,
September 1, 2003;
285(3):
C512 - C521.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Jia, M. Alaoui-El-Azher, M. Chow, T. C. Chambers, H. Baker, and S. Jin
c-Jun NH2-Terminal Kinase-Mediated Signaling Is Essential for Pseudomonas aeruginosa ExoS-Induced Apoptosis
Infect. Immun.,
June 1, 2003;
71(6):
3361 - 3370.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J Berkes, V K Viswanathan, S D Savkovic, and G Hecht
Intestinal epithelial responses to enteric pathogens: effects on the tight junction barrier, ion transport, and inflammation
Gut,
March 1, 2003;
52(3):
439 - 451.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. S. Long, K. Han, M. Li, S. Shirasawa, T. Sasazuki, M. Johnston, and M.-S. Tsao
Met Receptor Overexpression and Oncogenic Ki-ras Mutation Cooperate to Enhance Tumorigenicity of Colon Cancer Cells in Vivo
Mol. Cancer Res.,
March 1, 2003;
1(5):
393 - 401.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Suzuki, K. Akimoto, and S. Ohno
Protein Kinase C {lambda}/{iota} (PKC{lambda}/{iota}): A PKC Isotype Essential for the Development of Multicellular Organisms
J. Biochem.,
January 1, 2003;
133(1):
9 - 16.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Vogt, K. E. Pestell, B. W. Day, J. S. Lazo, and P. Wipf
The Antisignaling Agent SC-{alpha}{alpha}{delta}9, 4-(Benzyl-(2-[(2,5-diphenyloxazole- 4-carbonyl)amino]ethyl)carbamoyl)- 2-decanoylaminobutyric Acid, Is a Structurally Unique Phospholipid Analogue with Phospholipase C Inhibitory Activity
Mol. Cancer Ther.,
September 1, 2002;
1(11):
885 - 892.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. M. Lounsbury, M. Stern, D. Taatjes, S. Jaken, and B. T. Mossman
Increased Localization and Substrate Activation of Protein Kinase C{delta} in Lung Epithelial Cells following Exposure to Asbestos
Am. J. Pathol.,
June 1, 2002;
160(6):
1991 - 2000.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. T. Diaz-Meco and J. Moscat
MEK5, a New Target of the Atypical Protein Kinase C Isoforms in Mitogenic Signaling
Mol. Cell. Biol.,
February 15, 2001;
21(4):
1218 - 1227.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
E. C. Dempsey, A. C. Newton, D. Mochly-Rosen, A. P. Fields, M. E. Reyland, P. A. Insel, and R. O. Messing
Protein kinase C isozymes and the regulation of diverse cell responses
Am J Physiol Lung Cell Mol Physiol,
September 1, 2000;
279(3):
L429 - L438.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. C. Corbit, J.-W. Soh, K. Yoshida, E. M. Eves, I. B. Weinstein, and M. R. Rosner
Different Protein Kinase C Isoforms Determine Growth Factor Specificity in Neuronal Cells
Mol. Cell. Biol.,
August 1, 2000;
20(15):
5392 - 5403.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
M. P. Coghlan, M. M. Chou, and C. L. Carpenter
Atypical Protein Kinases Clambda and -zeta Associate with the GTP-Binding Protein Cdc42 and Mediate Stress Fiber Loss
Mol. Cell. Biol.,
April 15, 2000;
20(8):
2880 - 2889.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
M. T. Diaz-Meco, M.-J. Lallena, A. Monjas, S. Frutos, and J. Moscat
Inactivation of the Inhibitory kappa B Protein Kinase/Nuclear Factor kappa B Pathway by Par-4 Expression Potentiates Tumor Necrosis Factor alpha -induced Apoptosis
J. Biol. Chem.,
July 9, 1999;
274(28):
19606 - 19612.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. Mikkola, J.-A. Bruun, G. Bjorkoy, T. Holm, and T. Johansen
Phosphorylation of the Transactivation Domain of Pax6 by Extracellular Signal-regulated Kinase and p38 Mitogen-activated Protein Kinase
J. Biol. Chem.,
May 21, 1999;
274(21):
15115 - 15126.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Frutos, J. Moscat, and M. T. Diaz-Meco
Cleavage of zeta PKC but Not lambda /iota PKC by Caspase-3 during UV-induced Apoptosis
J. Biol. Chem.,
April 16, 1999;
274(16):
10765 - 10770.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Uberall, K. Hellbert, S. Kampfer, K. Maly, A. Villunger, M. Spitaler, J. Mwanjewe, G. Baier-Bitterlich, G. Baier, and H. H. Grunicke
Evidence That Atypical Protein Kinase C-lambda and Atypical Protein Kinase C-zeta Participate in Ras-mediated Reorganization of the F-actin Cytoskeleton
J. Cell Biol.,
February 8, 1999;
144(3):
413 - 425.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Kotani, W. Ogawa, M. Matsumoto, T. Kitamura, H. Sakaue, Y. Hino, K. Miyake, W. Sano, K. Akimoto, S. Ohno, et al.
Requirement of Atypical Protein Kinase Clambda for Insulin Stimulation of Glucose Uptake but Not for Akt Activation in 3T3-L1 Adipocytes
Mol. Cell. Biol.,
December 1, 1998;
18(12):
6971 - 6982.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
P. Lenormand, J.-M. Brondello, A. Brunet, and J. Pouyssegur
Growth Factor-induced p42/p44 MAPK Nuclear Translocation and Retention Requires Both MAPK Activation and Neosynthesis of Nuclear Anchoring Proteins
J. Cell Biol.,
August 10, 1998;
142(3):
625 - 633.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Luberto and Y. A. Hannun
Sphingomyelin Synthase, a Potential Regulator of Intracellular Levels of Ceramide and Diacylglycerol during SV40 Transformation. DOES SPHINGOMYELIN SYNTHASE ACCOUNT FOR THE PUTATIVE PHOSPHATIDYLCHOLINE-SPECIFIC PHOSPHOLIPASE C?
J. Biol. Chem.,
June 5, 1998;
273(23):
14550 - 14559.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Sanchez, G. De Carcer, I. V. Sandoval, J. Moscat, and M. T. Diaz-Meco
Localization of Atypical Protein Kinase C Isoforms into Lysosome-Targeted Endosomes through Interaction with p62
Mol. Cell. Biol.,
May 1, 1998;
18(5):
3069 - 3080.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
M. R. Deehan, M. J. Frame, R. M. E. Parkhouse, S. D. Seatter, S. D. Reid, M. M. Harnett, and W. Harnett
A Phosphorylcholine-Containing Filarial Nematode-Secreted Product Disrupts B Lymphocyte Activation by Targeting Key Proliferative Signaling Pathways
J. Immunol.,
March 15, 1998;
160(6):
2692 - 2699.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S.-L. Wu, J. Staudinger, E. N. Olson, and C. S. Rubin
Structure, Expression, and Properties of an Atypical Protein Kinase C (PKC3) from Caenorhabditis elegans. PKC3 IS REQUIRED FOR THE NORMAL PROGRESSION OF EMBRYOGENESIS AND VIABILITY OF THE ORGANISM
J. Biol. Chem.,
January 9, 1998;
273(2):
1130 - 1143.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Spitaler, A. Villunger, H. Grunicke, and F. Uberall
Unique Structural and Functional Properties of the ATP-binding Domain of Atypical Protein Kinase C-iota
J. Biol. Chem.,
October 20, 2000;
275(43):
33289 - 33296.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. W. Anthonsen, S. Andersen, A. Solhaug, and B. Johansen
Atypical lambda /iota PKC Conveys 5-Lipoxygenase/Leukotriene B4-mediated Cross-talk between Phospholipase A2s Regulating NF-kappa B Activation in Response to Tumor Necrosis Factor-alpha and Interleukin-1beta
J. Biol. Chem.,
September 14, 2001;
276(38):
35344 - 35351.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 1997 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|